Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 23 studies | 32% ± 17% | |
fibroblast | 20 studies | 23% ± 7% | |
endothelial cell | 12 studies | 41% ± 21% | |
smooth muscle cell | 10 studies | 39% ± 20% | |
adipocyte | 8 studies | 56% ± 12% | |
astrocyte | 6 studies | 35% ± 19% | |
ionocyte | 4 studies | 45% ± 17% | |
connective tissue cell | 4 studies | 28% ± 11% | |
renal alpha-intercalated cell | 4 studies | 23% ± 5% | |
podocyte | 3 studies | 33% ± 9% | |
extravillous trophoblast | 3 studies | 32% ± 13% | |
placental villous trophoblast | 3 studies | 60% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
placenta | 3 studies | 34% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 5931.44 | 241 / 245 | 94% | 9.04 | 473 / 502 |
thymus | 98% | 6572.68 | 638 / 653 | 89% | 14.76 | 541 / 605 |
kidney | 93% | 3606.31 | 83 / 89 | 79% | 22.28 | 712 / 901 |
intestine | 95% | 10376.30 | 920 / 966 | 72% | 4.59 | 377 / 527 |
breast | 99% | 13308.40 | 456 / 459 | 65% | 5.03 | 729 / 1118 |
brain | 64% | 1746.75 | 1703 / 2642 | 98% | 7.67 | 691 / 705 |
bladder | 100% | 13404.24 | 21 / 21 | 58% | 3.92 | 294 / 504 |
stomach | 85% | 5067.48 | 304 / 359 | 73% | 4.73 | 208 / 286 |
esophagus | 84% | 5571.07 | 1213 / 1445 | 60% | 4.01 | 110 / 183 |
ovary | 73% | 2222.70 | 131 / 180 | 70% | 7.71 | 299 / 430 |
lung | 87% | 3760.72 | 505 / 578 | 47% | 3.92 | 545 / 1155 |
uterus | 92% | 4384.26 | 157 / 170 | 32% | 2.86 | 145 / 459 |
pancreas | 26% | 532.03 | 86 / 328 | 89% | 12.75 | 159 / 178 |
adipose | 100% | 18906.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 9280.68 | 1299 / 1335 | 0% | 0 | 0 / 0 |
skin | 44% | 1445.00 | 788 / 1809 | 44% | 38.74 | 210 / 472 |
lymph node | 0% | 0 | 0 / 0 | 72% | 3.84 | 21 / 29 |
tonsil | 0% | 0 | 0 / 0 | 49% | 3.37 | 22 / 45 |
heart | 48% | 1450.68 | 417 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 17.66 | 2 / 258 | 43% | 3.13 | 100 / 230 |
muscle | 42% | 964.72 | 337 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 1.53 | 32 / 80 |
liver | 0% | 0 | 0 / 226 | 26% | 19.26 | 106 / 406 |
spleen | 1% | 14.56 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030212 | Biological process | hyaluronan metabolic process |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
Gene name | ITIH5 |
Protein name | Inter-alpha-trypsin inhibitor heavy chain 5 Inter-alpha (Globulin) inhibitor H5, isoform CRA_e (Inter-alpha-trypsin inhibitor heavy chain 5) Inter-alpha-trypsin inhibitor heavy chain H5 (ITI heavy chain H5) (ITI-HC5) (Inter-alpha-inhibitor heavy chain 5) |
Synonyms | hCG_25113 KIAA1953 UNQ311/PRO354 PP14776 |
Description | FUNCTION: May act as a tumor suppressor. |
Accessions | C9J2H1 H7C5A6 ENST00000397146.7 Q86UX2 G5E9D8 ENST00000613909.4 ENST00000397145.6 A0A096LP62 ENST00000461751.1 |